Դր.

main_info

  • trade_name:
  • Դր. Թայս ջղախոտ նշտարանման օշարակ
  • dosage:
  • 50մգ/գ100մլ և 250մլ ապակե շշիկ
  • pharmaceutical_form:
  • օշարակ
  • prescription_type:
  • Առանց դեղատոմսի
  • medicine_domain:
  • Human
  • medicine_type:
  • Allopathic

documents

localization

  • country:
  • Դր. Թայս ջղախոտ նշտարանման օշարակ
    አርሜኒያ
  • language:
  • አማርኛ

other_info

status

  • source:
  • Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում - Armenia
  • last_update:
  • 31-05-2018

22-4-2019

Statement from Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research, on FDA’s continued confidence in the safety and effectiveness of the measles, mumps, and rubella (MMR) vaccine

Statement from Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research, on FDA’s continued confidence in the safety and effectiveness of the measles, mumps, and rubella (MMR) vaccine

The FDA wants to underscore our continued confidence in the safety and effectiveness of the vaccines that are highly successful at preventing – in some cases, nearly eradicating – preventable diseases. Large well-designed studies have confirmed the safety and effectiveness of the MMR vaccine and have demonstrated that administration of the vaccine is not associated with the development of autism. MMR vaccine has been approved in the United States for nearly 50 years to prevent measles, mumps and rubella ...

FDA - U.S. Food and Drug Administration

18-4-2019

Safety of chia seeds (Salvia hispanica L.) as a novel food for extended uses pursuant to Regulation (EU) 2015/2283

Safety of chia seeds (Salvia hispanica L.) as a novel food for extended uses pursuant to Regulation (EU) 2015/2283

Published on: Wed, 17 Apr 2019 Following a request from the European Commission, the EFSA Panel on Nutrition, Novel foods and Food Allergens (NDA) was asked to deliver an opinion on overall safety assessment for chia seeds (Salvia hispanica L.) as a novel food (NF) pursuant to Regulation (EU) 2015/2283 in the light of the increasing dietary intake from the growing number of authorised uses in recent years. The safety assessment of this NF is based on data supplied in seven applications, previous safety ...

Europe - EFSA - European Food Safety Authority EFSA Journal

17-4-2019

Reporting data on pesticide residues in food and feed according to Regulation (EC) No 396/2005 (2018 data collection)

Reporting data on pesticide residues in food and feed according to Regulation (EC) No 396/2005 (2018 data collection)

Published on: Thu, 11 Apr 2019 According to Regulation (EC) No 396/2005 on maximum residue levels of pesticides in or on food and feed, Member States have to monitor pesticide residue levels in food samples and submit the monitoring results to EFSA and the European Commission. The Standard Sample Description (SSD, version 1) is the data model used for reporting the data on analytical measurements of chemical substances occurring in food, feed and water to EFSA. This document is a consolidated version of...

Europe - EFSA - European Food Safety Authority EFSA Journal

10-4-2019

Traumatic Brain Injury: What to Know About Symptoms, Diagnosis, and Treatment

Traumatic Brain Injury: What to Know About Symptoms, Diagnosis, and Treatment

Traumatic brain injury (TBI) can happen to anyone. And these types of injuries, which include concussions, contribute to a substantial number of emergency room visits, and even deaths, each year. Learn more about TBI. And note: If you have a head injury, seek medical attention right away. The FDA has not approved any devices that can assess or diagnose a concussion without an evaluation by a health care provider.

FDA - U.S. Food and Drug Administration

10-4-2019

Report on suspected side effects reported for medicinal cannabis

Report on suspected side effects reported for medicinal cannabis

Dizziness, nausea and concentration problems are some of the suspected side effects that have been reported to the Danish Medicines Agency in the first year of the medicinal cannabis pilot programme.

Danish Medicines Agency

9-4-2019

April 4, 2019: Houston Man Sentenced to Thirty Years in Prison for Money Laundering Conspiracy and Tax Crimes Relating to Second-Hand Drug Scheme

April 4, 2019: Houston Man Sentenced to Thirty Years in Prison for Money Laundering Conspiracy and Tax Crimes Relating to Second-Hand Drug Scheme

April 4, 2019: Houston Man Sentenced to Thirty Years in Prison for Money Laundering Conspiracy and Tax Crimes Relating to Second-Hand Drug Scheme

FDA - U.S. Food and Drug Administration

3-4-2019

FDA Posts Adverse Event Report Data for Animal Drugs and Devices Used in Animals to Increase Transparency

FDA Posts Adverse Event Report Data for Animal Drugs and Devices Used in Animals to Increase Transparency

In its continuing commitment to increase transparency, the U.S. Food and Drug Administration’s Center for Veterinary Medicine is announcing today the availability of data from over 30 years of adverse event reports related to animal drugs and devices used in animals.

FDA - U.S. Food and Drug Administration

28-3-2019

Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Subcommittee on Appropriations on FDA’s Fiscal Year 2020 budget

Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Subcommittee on Appropriations on FDA’s Fiscal Year 2020 budget

Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Subcommittee on Appropriations on FDA’s Fiscal Year 2020 budget.

FDA - U.S. Food and Drug Administration

7-3-2019

Re‐evaluation of Quillaia extract (E 999) as a food additive and safety of the proposed extension of use

Re‐evaluation of Quillaia extract (E 999) as a food additive and safety of the proposed extension of use

Published on: Wed, 06 Mar 2019 The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientific opinion on Quillaia extract (E 999) when used as a food additive and the evaluation of the safety of its proposed extension of use as a food additive in flavourings. The Scientific Committee for Food (SCF) in 1978 established an acceptable daily intake (ADI) of 0–5 mg spray‐dried extract/kg body weight (bw) per day for E 999. The Joint FAO/WHO Expert Committee on Food Additives ...

Europe - EFSA - European Food Safety Authority EFSA Journal

24-4-2019

Clopidogrel Apotex (Apotex Europe B.V.)

Clopidogrel Apotex (Apotex Europe B.V.)

Clopidogrel Apotex (Active substance: Clopidogrel) - Centralised - Yearly update - Commission Decision (2019)3158 of Wed, 24 Apr 2019

Europe -DG Health and Food Safety

24-4-2019

Semglee (Mylan S.A.S.)

Semglee (Mylan S.A.S.)

Semglee (Active substance: Insulin glargine) - Centralised - Yearly update - Commission Decision (2019)3176 of Wed, 24 Apr 2019

Europe -DG Health and Food Safety

24-4-2019

Clopidogrel HCS (HCS bvba)

Clopidogrel HCS (HCS bvba)

Clopidogrel HCS (Active substance: Clopidogrel) - Centralised - Yearly update - Commission Decision (2019)3155 of Wed, 24 Apr 2019

Europe -DG Health and Food Safety

24-4-2019

Cuprymina (SPARKLE S.r.l.)

Cuprymina (SPARKLE S.r.l.)

Cuprymina (Active substance: Copper 64Cu chloride) - Centralised - Yearly update - Commission Decision (2019)3175 of Wed, 24 Apr 2019

Europe -DG Health and Food Safety

24-4-2019

Caelyx (Janssen-Cilag International NV)

Caelyx (Janssen-Cilag International NV)

Caelyx (Active substance: Doxorubicin hydrochloride) - Centralised - Yearly update - Commission Decision (2019)3178 of Wed, 24 Apr 2019

Europe -DG Health and Food Safety

24-4-2019

SonoVue (Bracco International B.V.)

SonoVue (Bracco International B.V.)

SonoVue (Active substance: sulphur hexafluoride) - Centralised - Yearly update - Commission Decision (2019)3174 of Wed, 24 Apr 2019

Europe -DG Health and Food Safety

15-4-2019

Leganto (UCB Pharma S.A.)

Leganto (UCB Pharma S.A.)

Leganto (Active substance: Rotigotine) - Centralised - Yearly update - Commission Decision (2019)2992 of Mon, 15 Apr 2019

Europe -DG Health and Food Safety

15-4-2019

Lokelma (AstraZeneca AB)

Lokelma (AstraZeneca AB)

Lokelma (Active substance: sodium zirconium cyclosilicate) - Centralised - Yearly update - Commission Decision (2019)2987 of Mon, 15 Apr 2019

Europe -DG Health and Food Safety

15-4-2019

Convenia (Zoetis Belgium S.A.)

Convenia (Zoetis Belgium S.A.)

Convenia (Active substance: Cefovecin) - Centralised - Yearly update - Commission Decision (2019)2996 of Mon, 15 Apr 2019

Europe -DG Health and Food Safety

15-4-2019

Suvaxyn PRRS MLV (Zoetis Belgium S.A.)

Suvaxyn PRRS MLV (Zoetis Belgium S.A.)

Suvaxyn PRRS MLV (Active substance: Porcine respiratory and reproductive syndrome virus vaccine (live)) - Centralised - Yearly update - Commission Decision (2019)2995 of Mon, 15 Apr 2019

Europe -DG Health and Food Safety

15-4-2019

Lamivudine Teva (Teva B.V.)

Lamivudine Teva (Teva B.V.)

Lamivudine Teva (Active substance: Lamivudine) - Centralised - Yearly update - Commission Decision (2019)2994 of Mon, 15 Apr 2019

Europe -DG Health and Food Safety

15-4-2019

Pemetrexed Lilly (Eli Lilly Nederland B.V.)

Pemetrexed Lilly (Eli Lilly Nederland B.V.)

Pemetrexed Lilly (Active substance: pemetrexed) - Centralised - Yearly update - Commission Decision (2019)2986 of Mon, 15 Apr 2019

Europe -DG Health and Food Safety

15-4-2019

Zutectra (Biotest Pharma GmbH)

Zutectra (Biotest Pharma GmbH)

Zutectra (Active substance: Human Hepatitis B Immunoglobulin) - Centralised - Yearly update - Commission Decision (2019)2974 of Mon, 15 Apr 2019

Europe -DG Health and Food Safety

15-4-2019

Pregabalin Zentiva (Zentiva, k.s.)

Pregabalin Zentiva (Zentiva, k.s.)

Pregabalin Zentiva (Active substance: pregabalin) - Centralised - Yearly update - Commission Decision (2019)2990 of Mon, 15 Apr 2019

Europe -DG Health and Food Safety

15-4-2019

Spherox (CO.DON AG)

Spherox (CO.DON AG)

Spherox (Active substance: spheroids of human autologous matrix-associated chondrocytes) - Centralised - Yearly update - Commission Decision (2019)2972 of Mon, 15 Apr 2019

Europe -DG Health and Food Safety

15-4-2019

Cervarix (GlaxoSmithKline Biologicals S.A.)

Cervarix (GlaxoSmithKline Biologicals S.A.)

Cervarix (Active substance: Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins) - Centralised - Yearly update - Commission Decision (2019)2973 of Mon, 15 Apr 2019

Europe -DG Health and Food Safety

11-4-2019

Esbriet (Roche Registration GmbH)

Esbriet (Roche Registration GmbH)

Esbriet (Active substance: Pirfenidone) - Centralised - Yearly update - Commission Decision (2019)2883 of Thu, 11 Apr 2019

Europe -DG Health and Food Safety

10-4-2019

Iressa (AstraZeneca AB)

Iressa (AstraZeneca AB)

Iressa (Active substance: gefitinib) - Centralised - Yearly update - Commission Decision (2019)2823 of Wed, 10 Apr 2019

Europe -DG Health and Food Safety

10-4-2019

Lantus (Sanofi-Aventis Deutschland GmbH)

Lantus (Sanofi-Aventis Deutschland GmbH)

Lantus (Active substance: insulin glargine) - Centralised - Yearly update - Commission Decision (2019)2815 of Wed, 10 Apr 2019

Europe -DG Health and Food Safety

10-4-2019

Zerit (Bristol-Myers Squibb Pharma EEIG)

Zerit (Bristol-Myers Squibb Pharma EEIG)

Zerit (Active substance: Stavudine) - Centralised - Yearly update - Commission Decision (2019)2819 of Wed, 10 Apr 2019

Europe -DG Health and Food Safety

10-4-2019

Actraphane (Novo Nordisk A/S)

Actraphane (Novo Nordisk A/S)

Actraphane (Active substance: Insulin human (rDNA)) - Centralised - Yearly update - Commission Decision (2019)2813 of Wed, 10 Apr 2019

Europe -DG Health and Food Safety

10-4-2019

Orencia (Bristol-Myers Squibb Pharma EEIG)

Orencia (Bristol-Myers Squibb Pharma EEIG)

Orencia (Active substance: abatacept) - Centralised - Yearly update - Commission Decision (2019)2818 of Wed, 10 Apr 2019

Europe -DG Health and Food Safety

4-4-2019

Yervoy (Bristol-Myers Squibb/Pfizer EEIG)

Yervoy (Bristol-Myers Squibb/Pfizer EEIG)

Yervoy (Active substance: ipilimumab) - Centralised - Yearly update - Commission Decision (2019)2704 of Thu, 04 Apr 2019

Europe -DG Health and Food Safety

4-4-2019

NULOJIX (Bristol-Myers Squibb/Pfizer EEIG)

NULOJIX (Bristol-Myers Squibb/Pfizer EEIG)

NULOJIX (Active substance: belatacept) - Centralised - Yearly update - Commission Decision (2019)2703 of Thu, 04 Apr 2019

Europe -DG Health and Food Safety

4-4-2019

Clopidogrel BGR (Laboratoires BIOGARAN)

Clopidogrel BGR (Laboratoires BIOGARAN)

Clopidogrel BGR (Active substance: Clopidogrel) - Centralised - Yearly update - Commission Decision (2019)2694 of Thu, 04 Apr 2019

Europe -DG Health and Food Safety

4-4-2019

Empliciti (Bristol-Myers Squibb Pharma EEIG)

Empliciti (Bristol-Myers Squibb Pharma EEIG)

Empliciti (Active substance: elotuzumab) - Centralised - Yearly update - Commission Decision (2019)2692 of Thu, 04 Apr 2019

Europe -DG Health and Food Safety

4-4-2019

Zonisamide Mylan (Mylan S.A.S.)

Zonisamide Mylan (Mylan S.A.S.)

Zonisamide Mylan (Active substance: zonisamide) - Centralised - Yearly update - Commission Decision (2019)2715 of Thu, 04 Apr 2019

Europe -DG Health and Food Safety

2-4-2019

Half yearly performance snapshot: July to December 2018

Half yearly performance snapshot: July to December 2018

The 2018 Half Yearly Performance Snapshot is now available

Therapeutic Goods Administration - Australia

1-4-2019

NovoRapid (Novo Nordisk A/S)

NovoRapid (Novo Nordisk A/S)

NovoRapid (Active substance: Insulin aspart) - Centralised - Yearly update - Commission Decision (2019)2596 of Mon, 01 Apr 2019

Europe -DG Health and Food Safety

1-4-2019

Mixtard (Novo Nordisk A/S)

Mixtard (Novo Nordisk A/S)

Mixtard (Active substance: Insulin human (rDNA)) - Centralised - Yearly update - Commission Decision (2019)2598 of Mon, 01 Apr 2019

Europe -DG Health and Food Safety

1-4-2019

Insulatard (Novo Nordisk A/S)

Insulatard (Novo Nordisk A/S)

Insulatard (Active substance: Insulin human (rDNA)) - Centralised - Yearly update - Commission Decision (2019)2597 of Mon, 01 Apr 2019

Europe -DG Health and Food Safety

1-4-2019

Imatinib Teva (Teva B.V.)

Imatinib Teva (Teva B.V.)

Imatinib Teva (Active substance: imatinib) - Centralised - Yearly update - Commission Decision (2019)2595 of Mon, 01 Apr 2019

Europe -DG Health and Food Safety

1-4-2019

Lamivudine / Zidovudine Teva (Teva B.V.)

Lamivudine / Zidovudine Teva (Teva B.V.)

Lamivudine / Zidovudine Teva (Active substance: Lamivudine / Zidovudine) - Centralised - Yearly update - Commission Decision (2019)2576 of Mon, 01 Apr 2019

Europe -DG Health and Food Safety

1-4-2019

Clopidogrel Krka (Krka d. d., Novo mesto)

Clopidogrel Krka (Krka d. d., Novo mesto)

Clopidogrel Krka (Active substance: Clopidogrel) - Centralised - Yearly update - Commission Decision (2019)2594 of Mon, 01 Apr 2019

Europe -DG Health and Food Safety

1-4-2019

VPRIV (Shire Pharmaceuticals Ireland Limited)

VPRIV (Shire Pharmaceuticals Ireland Limited)

VPRIV (Active substance: Velaglucerase alfa) - Centralised - Yearly update - Commission Decision (2019)2575 of Mon, 01 Apr 2019

Europe -DG Health and Food Safety

29-3-2019

Activyl Tick Plus (Intervet International B.V.)

Activyl Tick Plus (Intervet International B.V.)

Activyl Tick Plus (Active substance: Indoxacarb + permethrin) - Centralised - Yearly update - Commission Decision (2019)2544 of Fri, 29 Mar 2019

Europe -DG Health and Food Safety

28-3-2019


20 years of sampling and testing of centrally authorised products: 1998 – 2017

20 years of sampling and testing of centrally authorised products: 1998 – 2017

20 years of sampling and testing of centrally authorised products: 1998 – 2017

Europe - EMA - European Medicines Agency

28-3-2019


20 years of sampling and testing programme for medicines authorised for the EU

20 years of sampling and testing programme for medicines authorised for the EU

20 years of sampling and testing programme for medicines authorised for the EU

Europe - EMA - European Medicines Agency

27-3-2019

Clopidogrel Mylan (Mylan S.A.S.)

Clopidogrel Mylan (Mylan S.A.S.)

Clopidogrel Mylan (Active substance: Clopidogrel) - Centralised - Yearly update - Commission Decision (2019)2388 of Wed, 27 Mar 2019

Europe -DG Health and Food Safety

27-3-2019

Levemir (Novo Nordisk A/S)

Levemir (Novo Nordisk A/S)

Levemir (Active substance: insulin detemir) - Centralised - Yearly update - Commission Decision (2019)2389 of Wed, 27 Mar 2019

Europe -DG Health and Food Safety

27-3-2019

Baraclude (Bristol-Myers Squibb Pharma EEIG)

Baraclude (Bristol-Myers Squibb Pharma EEIG)

Baraclude (Active substance: entecavir) - Centralised - Yearly update - Commission Decision (2019)2391 of Wed, 27 Mar 2019

Europe -DG Health and Food Safety

27-3-2019

Edarbi (Takeda Pharma A/S)

Edarbi (Takeda Pharma A/S)

Edarbi (Active substance: azilsartan medoxomil) - Centralised - Yearly update - Commission Decision (2019)2386 of Wed, 27 Mar 2019

Europe -DG Health and Food Safety

27-3-2019

Zyllt (Krka d. d., Novo mesto)

Zyllt (Krka d. d., Novo mesto)

Zyllt (Active substance: Clopidogrel) - Centralised - Yearly update - Commission Decision (2019)2377 of Wed, 27 Mar 2019

Europe -DG Health and Food Safety

27-3-2019

Clopidogrel ratiopharm GmbH (Archie Samuel s.r.o.)

Clopidogrel ratiopharm GmbH (Archie Samuel s.r.o.)

Clopidogrel ratiopharm GmbH (Active substance: Clopidogrel) - Centralised - Yearly update - Commission Decision (2019)2390 of Wed, 27 Mar 2019

Europe -DG Health and Food Safety

27-3-2019

ADYNOVI (Baxalta Innovations GmbH)

ADYNOVI (Baxalta Innovations GmbH)

ADYNOVI (Active substance: rurioctocog alfa pegol) - Centralised - Yearly update - Commission Decision (2019)2378 of Wed, 27 Mar 2019

Europe -DG Health and Food Safety

27-3-2019

Lutathera (Advanced Accelerator Applications)

Lutathera (Advanced Accelerator Applications)

Lutathera (Active substance: lutetium (177Lu) oxodotreotide) - Centralised - Yearly update - Commission Decision (2019)2376 of Wed, 27 Mar 2019

Europe -DG Health and Food Safety

20-3-2019

Today is #KickButtsDay. Take some time today to learn facts about the harms of smoking. 
#FACT Tobacco use causes more than 480,000 deaths each year in the United States. Find out more information to quit tobacco:  https://go.usa.gov/xEWdT  via @FDATobacc

Today is #KickButtsDay. Take some time today to learn facts about the harms of smoking. #FACT Tobacco use causes more than 480,000 deaths each year in the United States. Find out more information to quit tobacco: https://go.usa.gov/xEWdT  via @FDATobacc

Today is #KickButtsDay. Take some time today to learn facts about the harms of smoking. #FACT Tobacco use causes more than 480,000 deaths each year in the United States. Find out more information to quit tobacco: https://go.usa.gov/xEWdT  via @FDATobacco pic.twitter.com/vOvAFo6jO1

FDA - U.S. Food and Drug Administration

15-3-2019

Ongentys (Bial - Portela and Ca, SA)

Ongentys (Bial - Portela and Ca, SA)

Ongentys (Active substance: opicapone) - Centralised - Yearly update - Commission Decision (2019)2113 of Fri, 15 Mar 2019

Europe -DG Health and Food Safety

14-3-2019

Suprelorin (VIRBAC S.A.)

Suprelorin (VIRBAC S.A.)

Suprelorin (Active substance: Deslorelin acetate) - Centralised - Yearly update - Commission Decision (2019)2087 of Thu, 14 Mar 2019

Europe -DG Health and Food Safety

13-3-2019

Actrapid (Novo Nordisk A/S)

Actrapid (Novo Nordisk A/S)

Actrapid (Active substance: Insulin human (rDNA)) - Centralised - Yearly update - Commission Decision (2019)2070 of Wed, 13 Mar 2019

Europe -DG Health and Food Safety

13-3-2019

Herceptin (Roche Registration GmbH)

Herceptin (Roche Registration GmbH)

Herceptin (Active substance: trastuzumab) - Centralised - Yearly update - Commission Decision (2019) 2059 of Wed, 13 Mar 2019

Europe -DG Health and Food Safety

13-3-2019

INOmax (Linde Healthcare AB)

INOmax (Linde Healthcare AB)

INOmax (Active substance: Nitric oxide) - Centralised - Yearly update - Commission Decision (2019)2060 of Wed, 13 Mar 2019

Europe -DG Health and Food Safety

7-3-2019

Levetiracetam Actavis (Actavis Group PTC ehf.)

Levetiracetam Actavis (Actavis Group PTC ehf.)

Levetiracetam Actavis (Active substance: levetiracetam) - Centralised - Yearly update - Commission Decision (2019)1911 of Thu, 07 Mar 2019

Europe -DG Health and Food Safety

5-3-2019

Prevomax (Le Vet Beheer B.V.)

Prevomax (Le Vet Beheer B.V.)

Prevomax (Active substance: maropitant) - Centralised - Yearly update - Commission Decision (2019)1823 of Tue, 05 Mar 2019

Europe -DG Health and Food Safety

5-3-2019

Herzuma (Celltrion Healthcare Hungary Kft.)

Herzuma (Celltrion Healthcare Hungary Kft.)

Herzuma (Active substance: trastuzumab) - Centralised - Yearly update - Commission Decision (2019)1830 of Tue, 05 Mar 2019

Europe -DG Health and Food Safety